These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38408281)

  • 1. Network Meta-Analysis Indicates Superior Effects of Omega-3 Polyunsaturated Fatty Acids in Preventing the Transition to Psychosis in Individuals at Clinical High-Risk.
    Chen C; Deng Y; Li Y; Zhang M; Yu T; Xie K; Bao W; Li P; Sun L; Zhang T; Zhu Y; Zhang B
    Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 38408281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for prodromal stage of psychosis.
    Bosnjak Kuharic D; Kekin I; Hew J; Rojnic Kuzman M; Puljak L
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31689359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis.
    Devoe DJ; Farris MS; Townes P; Addington J
    Early Interv Psychiatry; 2019 Feb; 13(1):3-17. PubMed ID: 29749710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early interventions to prevent psychosis: systematic review and meta-analysis.
    Stafford MR; Jackson H; Mayo-Wilson E; Morrison AP; Kendall T
    BMJ; 2013 Jan; 346():f185. PubMed ID: 23335473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.
    Robinson DG; Gallego JA; John M; Hanna LA; Zhang JP; Birnbaum ML; Greenberg J; Naraine M; Peters BD; McNamara RK; Malhotra AK; Szeszko PR
    Schizophr Res; 2019 Feb; 204():295-303. PubMed ID: 30241990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis.
    Devoe DJ; Peterson A; Addington J
    Schizophr Bull; 2018 Jun; 44(4):807-823. PubMed ID: 29069511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions and Transition in Youth at Risk of Psychosis: A Systematic Review and Meta-Analyses.
    Devoe DJ; Farris MS; Townes P; Addington J
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32433834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
    McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EY; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP
    JAMA Psychiatry; 2017 Jan; 74(1):19-27. PubMed ID: 27893018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.
    McGorry PD; Nelson B; Phillips LJ; Yuen HP; Francey SM; Thampi A; Berger GE; Amminger GP; Simmons MB; Kelly D; Dip G; Thompson AD; Yung AR
    J Clin Psychiatry; 2013 Apr; 74(4):349-56. PubMed ID: 23218022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB study.
    Qurashi I; Chaudhry IB; Khoso AB; Omair Husain M; Hafeez D; Kiran T; Lane S; Naqvi HA; Minhas FA; Tamizuddin Nizami A; Razzaque B; Qambar Bokhari S; Yung AR; Deakin B; Husain N
    Brain Behav Immun; 2024 Jan; 115():609-616. PubMed ID: 37924960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis.
    Oliva V; Possidente C; De Prisco M; Fico G; Anmella G; Hidalgo-Mazzei D; Murru A; Fanelli G; Fabbri C; Fornaro M; de Bartolomeis A; Solmi M; Radua J; Vieta E; Serretti A
    Lancet Psychiatry; 2024 Mar; 11(3):210-220. PubMed ID: 38360024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Leach MJ; Perez Algorta G
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007986. PubMed ID: 37058600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.
    Salazar de Pablo G; Radua J; Pereira J; Bonoldi I; Arienti V; Besana F; Soardo L; Cabras A; Fortea L; Catalan A; Vaquerizo-Serrano J; Coronelli F; Kaur S; Da Silva J; Shin JI; Solmi M; Brondino N; Politi P; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2021 Sep; 78(9):970-978. PubMed ID: 34259821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis.
    Lam C; Han L; McIntyre RS; Teopiz KM; Cao B
    J Child Adolesc Psychopharmacol; 2024 Sep; 34(7):282-291. PubMed ID: 38959193
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.